Slim down without sacrificing muscle? a protein supplement may help

NCT ID NCT07772908

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests whether a daily protein supplement, combined with resistance training, can prevent muscle loss during weight loss. Healthy adults aged 25 to 60 will follow a four-month program with clinical assessments, proper nutrition, and physical activity. Researchers will measure changes in fat-free mass to see if the supplement helps preserve muscle while shedding pounds.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A protein supplement taken once daily, combined with resistance training
What this could lead to
If effective, this approach could help people lose weight while preserving muscle mass, supporting healthier aging and long-term metabolic health.
What could go wrong
The trial is small and early, and results may not apply to everyone. The supplement's benefit over placebo is unproven, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants of both sexes aged between 25 and 60 years. * Ability to understand and accept participation in the study, indicated by signing the Informed Consent Form approved by the Ethics Committee. * Good health status, determined by the absence of significant findings in medical history, physical examination, laboratory tests, and vital sign measurements. * Agree to comply with the planned study procedures and attend visits. * Participants with the capacity and motivation to perform resistance training 3 to 5 times per week (150 to 200 minutes/week); - Participants with a body mass index (BMI) ≥ 27.0 kg/m². Exclusion Criteria: * Known allergy to components of the investigational product or placebo; * History of chronic use in the last 3 months or current use of medications or substances that affect the muscular system; * Current history of type 1 or 2 diabetes mellitus, gastrointestinal, cardiovascular, renal, or hepatic diseases, or malignant neoplasm, considered clinically significant at the physician's discretion. * Abuse of illicit drugs or alcohol, as clinically assessed by the investigator during screening. * Having participated in a clinical study in the last 12 months at the investigator's discretion. * Having any condition that prevents participation in the study at the investigator's discretion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prevention of muscle mass loss are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Althaia SA Indústria Farmacêutica

    Atibaia, São Paulo, Brazil